Follow The Filings

CRVO CervoMed

CervoMed earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CRVO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CRVO insider trades
  • $3.7M bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Joshua S Boger Director
    Buy
    $3M 955,414 shares at $3.14 +114% to stake
    Traded Jun 11 Filed Jun 15
    ↗
  2. Matthew Winton Chief Commercial and Business
    Buy
    $41K 5,000 shares at $8.29 +50% to stake
    Traded Nov 17–18 Filed Nov 19, 2025
    ↗
  3. Sylvie Gregoire Director
    Buy
    $183K 21,600 shares at $8.46
    Traded Nov 17, 2025 Filed Nov 19, 2025
    ↗
  4. William Robert Elder CFO
    Buy
    $29K 3,500 shares at $8.36 +39% to stake
    Traded Nov 17–18 Filed Nov 19, 2025
    ↗
  5. Sylvie Gregoire Director
    Buy
    $59K 7,847 shares at $7.53
    Traded Nov 13–14 Filed Nov 17, 2025
    ↗
  6. Matthew Winton Chief Commercial and Business
    Buy
    $76K 10,000 shares at $7.57 New stake
    Traded Nov 14, 2025 Filed Nov 17, 2025
    ↗
  7. Sylvie Gregoire Director
    Buy
    $41K 5,553 shares at $7.35 +0.4% to stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
    ↗
  8. William Robert Elder CFO
    Buy
    $26K 3,500 shares at $7.44 +64% to stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B3 FORM 424B3 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc
424B5 FORM 424B5 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,3.02,7.01,8.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 9 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.